 ADC Therapeutics SA NYSE:ADCT Q2 2020 Earnings Conference Call August 18, 2020, 08:30 ET Company Participants Amanda Hamilton - IR Officer Christopher Martin - CEO Director Jay Feingold - Chief Medical Officer, Head, Oncology Clinical Development Senior VP Jennifer Creel - CFO Conference Call Participants Tazeen Ahmad - Bank of America Merrill Lynch Matthew Harrison - Morgan Stanley Boris Peaker - Cowen and Company Presentation Operator Ladies and gentlemen, welcome to the ADC Therapeutics Q2 Earnings Call. 